Iron isomaltoside 1000: all 54 studies that test it

Page 1 of 1. Open to participants first (8), then studies with results posted, then the rest; newest registration first within each.

• Study on Supplement of Intravenous Ferric Derisomaltose to Prevent Anemia and Improve the Quality of Life in Obese Patients With Iron Deficiency.RecruitingNCT07236788Not applicable
• Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN StudyRecruitingNCT06884280Phase 3
• Iron Isomaltoside for the Treatment of Anemia in Peritoneal Dialysis PatientsNot yet recruitingNCT06830941Phase 4
• IV Iron-induced Hypophosphatemia After RYGBRecruitingNCT06350955Phase 4
• Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal CarcinomaRecruitingNCT05913414Phase 2
• The Effect of Intravenous Iron Therapy and Erythropoiesis-stimulation Agent Combination on Renal Transplant OutcomesNot yet recruitingNCT05719376Phase 4
• Oral Versus Intravenous Iron in IBD Patients With Anti-inflammatory Therapy.RecruitingNCT05581420Not applicable
• Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in PregnancyRecruitingNCT05251493Phase 3
• Intravenous Iron Supplement for Iron Deficiency in Patients With Severe Aortic StenosisCompletedNCT04206228Phase 2Results posted
• Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant RecipientsCompletedNCT03662789Phase 2/3Results posted
• Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency AnaemiaCompletedNCT03238911Phase 3Results posted
• Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency AnaemiaCompletedNCT03237065Phase 3Results posted
• An Extension Trial to Assess the Safety of Re-dosing of Iron Isomaltoside/Ferric Derisomaltose (Monofer®/Monoferric®)CompletedNCT02962648Phase 3Results posted
• Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)CompletedNCT02940886Phase 3Results posted
• Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney DiseaseCompletedNCT02940860Phase 3Results posted
• IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron SucroseCompletedNCT02130063Phase 3Results posted
• A Randomized, Comparative, Open-label Study of IV Monofer® Administered as Maintenance Therapy by Single or Repeated Bolus Injections in Comparison With IV Iron Sucrose in Subjects With CKD-5DCompletedNCT01222884Phase 3Results posted
• A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoiesis Stimulating Agents) in Comparison With Oral Iron Sulfate in Subjects With Non-myeloid Malignancies Associated With Chemotherapy Induced Anaemia (CIA)CompletedNCT01145638Phase 3Results posted
• Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related AnaemiaCompletedNCT01102413Phase 3Results posted
• Reducing Anemia in Pregnancy in India: the RAPIDIRON TrialCompletedNCT05358509Phase 4
• Single Dose Intravenous Iron Isomaltoside in Combination With Oral Iron vs Oral Iron Monotherapy in Patients With Anemia After Postpartum HaemorrhageStatus unknownNCT04505514Phase 4
• Effect of Preoperative Iron Isomaltoside 1000 Administration on Hemoglobin Concentration in Patients Undergoing Transcatheter Aortic Valve ImplantationStatus unknownNCT04346004Phase 4
• Effect of Intravenous Iron Supplementation in Reducing Allogenic Blood TransfusionCompletedNCT04061655Early Phase 1
• Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum AnemiaCompletedNCT03957057Phase 3
• ProPBM : A Modified Patient Blood Management ProtocolStatus unknownNCT03888768Not applicable
• Iron Isomaltoside Compared With Iron Sucrosein Peritoneal Dialysis PatientsTerminatedNCT03610230Not applicable
• Efficacy of Preoperative Intravenous Iron in Anaemic Colorectal Cancer Surgical PatientsCompletedNCT03565354Phase 3
• Effect of IV Iron Isomaltoside on Postoperative Anemia in Total Knee Arthroplasty PatientsCompletedNCT03470649Not applicable
• A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Due to Inflammatory Bowel DiseaseCompletedNCT03466983Phase 4
• Intravenous Iron Isomaltoside 1000 (Monofer®) Compared With Oral Iron in the Treatment of Postgastrectomy Anemia: An Open-label Randomized Controlled TrialStatus unknownNCT03229954Phase 4
• Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy.CompletedNCT03188445Phase 4
• Efficacy of Intravenous Iron Therapy in Maintaining Hemoglobin Concentration on Patients Undergoing Bimaxillary Orthognathic SurgeryStatus unknownNCT03094182Not applicable
• Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®)CompletedNCT03013439Phase 1
• Intravenous Iron for Correction of Anaemia After Colorectal SurgeryStatus unknownNCT02999217Phase 4
• HiFIT Study : Hip Fracture: Iron and Tranexamic AcidTerminatedNCT02972294Phase 3
• A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or MonoferCompletedNCT02905539Phase 4
• Effect of Perioperative Iron Isomaltoside 1000 Administration on Transfusion Requirements in Patients Undergoing Complex Valvular Heart Surgery: a Randomized Clinical TrialCompletedNCT02862665Not applicable
• IV Iron Treatment of Restless Legs SyndromeWithdrawnNCT02484768Phase 2
• A Randomized, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against PlaceboWithdrawnNCT02172001Phase 3
• Iron Replacement in Oesophagogastric NeoplasiaStatus unknownNCT01927328Phase 4
• A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Iron-deficient Blood DonorsCompletedNCT01895231Phase 3
• Treatment of Women After Postpartum HaemorrhageCompletedNCT01895218Phase 3
• Treatment of Women After Severe Postpartum HaemorrhageCompletedNCT01895205Phase 3
• Use of Iron Isomaltoside 1000 (Monofer) in Postpartum AnemiaCompletedNCT01628770Not applicable
• Iron Isomaltoside 1000 (Monofer®) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel DiseaseCompletedNCT01599702Phase 3
• A Prospective, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Non-Anaemic Patients Undergoing Elective or Sub-Acute Coronary Artery Bypass Graft, Valve Replacement or a Combination ThereofCompletedNCT01563367Phase 3
• Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered as Single Bolus Injections in Subjects With Stage 5 Chronic Kidney Disease on Dialysis Therapy (CKD-5D)CompletedNCT01469078Phase 1
• Safety and Efficacy Extension Study of Iron Isomaltoside 1000 (Monofer®) in Subjects With Inflammatory Bowel DiseaseCompletedNCT01410435Phase 3
• Pharmacokinetic Study of Iron Isomaltoside 1000 Administered by 250 mg IV Bolus Injection or 500 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced AnaemiaCompletedNCT01280240Phase 1
• Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous to Patients With CKDCompletedNCT01213992Phase 1
• Open-label PK Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg IV Injection or 1000 mg IV Infusion to Patients With Inflammatory Bowel DiseaseCompletedNCT01213680Phase 1
• Iron Oligosaccharide in Inflammatory Bowel Disease Subjects With Iron Deficiency AnaemiaCompletedNCT01017614Phase 3
• A Study of Iron Oligosaccharide in CHF PatientsCompletedNCT00537186Phase 3
• A Study of Iron Oligosaccharide in Chronic Kidney Disease PatientsCompletedNCT00536666Phase 3

← Iron isomaltoside 1000 overview